{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:44Z","timestamp":1790400164788,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T00:00:00Z","timestamp":1217894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s10689-008-9206-8","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T21:21:44Z","timestamp":1217884904000},"page":"29-32","source":"Crossref","is-referenced-by-count":12,"title":["Absence of founder BRCA1 and BRCA2 mutations in coetaneous malignant melanoma patients of Ashkenazi origin"],"prefix":"10.1007","volume":"8","author":[{"given":"Luna","family":"Kadouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Temper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Grenader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dvorah","family":"Abeliovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Hamburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Lotem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,5]]},"reference":[{"key":"9206_CR1","first-page":"774","volume":"6","author":"S Stahl","year":"2004","unstructured":"Stahl S, Bar-Meir E, Friedman E et al (2004) Genetics of melanoma. Isr Med Assoc J 6:774\u2013777","journal-title":"Isr Med Assoc J"},{"key":"9206_CR2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"The Breast Cancer Linkage Consortium","year":"1999","unstructured":"The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310\u20131316. doi: 10.1093\/jnci\/91.15.1310","journal-title":"J Natl Cancer Inst"},{"key":"9206_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","volume":"61","author":"DF Easton","year":"1997","unstructured":"Easton DF, Steele L, Fields P et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12\u201313. Am J Hum Genet 61:120\u2013128. doi: 10.1086\/513891","journal-title":"Am J Hum Genet"},{"key":"9206_CR4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"9206_CR5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) The Breast Cancer Linkage Consortium cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"9206_CR6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401\u20131408. doi: 10.1056\/NEJM199705153362001","journal-title":"N Engl J Med"},{"key":"9206_CR7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","volume":"94","author":"CB Begg","year":"2002","unstructured":"Begg CB (2002) On the use of familial aggregation in population based case probands for calculating penetrance. J Natl Cancer Inst 94:1221\u20131226","journal-title":"J Natl Cancer Inst"},{"key":"9206_CR8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/94.18.1344","volume":"94","author":"SB Gruber","year":"2002","unstructured":"Gruber SB, Petersen GM (2002) Cancer risks in BRCA1 carriers: time for the next generation of studies. J Natl Cancer Inst 94:1344\u20131345","journal-title":"J Natl Cancer Inst"},{"key":"9206_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jnci\/djh008","volume":"96","author":"BL Niell","year":"2004","unstructured":"Niell BL, Rennert G, Bonner JD et al (2004) BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 96:15\u201321","journal-title":"J Natl Cancer Inst"},{"key":"9206_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/1042819021000040332","volume":"44","author":"O Yossepowitch","year":"2003","unstructured":"Yossepowitch O, Olvera N, Satagopan JM et al (2003) BRCA1 and BRCA2 germline mutations in lymphoma patients. Leuk Lymphoma 44:127\u2013131. doi: 10.1080\/1042819021000040332","journal-title":"Leuk Lymphoma"},{"key":"9206_CR11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/302525","volume":"65","author":"A Hubert","year":"1999","unstructured":"Hubert A, Peretz T, Manor O et al (1999) The Jewish Ashkenazi founder mutations in the BRCA1\/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet 65:921\u2013924. doi: 10.1086\/302525","journal-title":"Am J Hum Genet"},{"key":"9206_CR12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/humu.10123","volume":"20","author":"CM Phelan","year":"2002","unstructured":"Phelan CM, Kwan E, Jack E et al (2002) A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat 20:352\u2013357. doi: 10.1002\/humu.10123","journal-title":"Hum Mutat"},{"key":"9206_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ijc.10155","volume":"98","author":"J Iscovich","year":"2002","unstructured":"Iscovich J, Abdulrazik M, Cour C et al (2002) Prevalence of BRCA2 6174delT mutation in Israeli uveal melanoma patients. Int J Cancer 98:42\u201344. doi: 10.1002\/ijc.10155","journal-title":"Int J Cancer"},{"key":"9206_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1167\/iovs.02-0026","volume":"44","author":"N Hearle","year":"2003","unstructured":"Hearle N, Damato BE, Humphreys J et al (2003) Contribution of germline mutations in BRCA2, P16 (INK4A), P14 (ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 44:458\u2013462. doi: 10.1167\/iovs.02-0026","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9206_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jmg.2003.016907","volume":"41","author":"MT Landi","year":"2004","unstructured":"Landi MT, Goldstein AM, Tsang S et al (2004) Genetic susceptibility in familial melanoma from northeastern Italy. J Med Genet 41:557\u2013566. doi: 10.1136\/jmg.2003.016907","journal-title":"J Med Genet"},{"key":"9206_CR16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ijc.20322","volume":"111","author":"W Goggins","year":"2004","unstructured":"Goggins W, Gao W, Tsao H (2004) Association between female breast cancer and cutaneous melanoma. Int J Cancer 111:792\u2013794. doi: 10.1002\/ijc.20322","journal-title":"Int J Cancer"},{"key":"9206_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/1097-0215(20001001)88:1<87::AID-IJC14>3.0.CO;2-F","volume":"88","author":"K Hemminki","year":"2000","unstructured":"Hemminki K, Vaittinen P, Easton D (2000) Familial cancer risks to offspring from mothers with 2 primary breast cancers: leads to cancer syndromes. Int J Cancer 88:87\u201391. doi: 10.1002\/1097-0215(20001001)88:1\u00a0\u2264\u00a087::AID-IJC14\u00a0\u2265\u00a03.0.CO;2-F","journal-title":"Int J Cancer"},{"key":"9206_CR18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.1534","volume":"94","author":"HS Evans","year":"2001","unstructured":"Evans HS, Lewis CM, Robinson D et al (2001) Cancer risks in women with 2 breast or ovarian cancers: clues to genetic cancer susceptibility. Int J Cancer 94:758\u2013759. doi: 10.1002\/ijc.1534","journal-title":"Int J Cancer"},{"key":"9206_CR19","doi-asserted-by":"crossref","unstructured":"van Asperen CJ, Brohet RM, Meijers-Heijboer EJ et\u00a0al, Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON) (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42:711\u2013719 doi: 10.1136\/jmg.2004.028829","DOI":"10.1136\/jmg.2004.028829"},{"key":"9206_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:FAME.0000026816.32400.45","volume":"3","author":"J Lubinski","year":"2004","unstructured":"Lubinski J, Phelan CM, Ghadirian P et al (2004) Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer 3:1\u201310. doi: 10.1023\/B:FAME.0000026816.32400.45","journal-title":"Fam Cancer"},{"key":"9206_CR21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1054\/bjoc.2001.1777","volume":"85","author":"L Kadouri","year":"2001","unstructured":"Kadouri L, Easton DF, Edwards S et al (2001) CAG and GGC repeat polymorphism in the androgen receptor gene and breast cancer susceptibility in BRCA1\/2 carriers and non-carriers. Br J Cancer 85:36\u201340. doi: 10.1054\/bjoc.2001.1777","journal-title":"Br J Cancer"},{"key":"9206_CR22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.bjc.6601837","volume":"90","author":"L Kadouri","year":"2004","unstructured":"Kadouri L, Kote-Jarai Z, Hubert A et al (2004) A single nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 but not in BRCA1 carriers or non-carriers. Br J Cancer 90:2002\u20132005. doi: 10.1038\/sj.bjc.6601837","journal-title":"Br J Cancer"},{"key":"9206_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ijc.11531","volume":"108","author":"L Kadouri","year":"2004","unstructured":"Kadouri L, Kote-Jarai Z, Easton EF et al (2004) Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. Int J Cancer 108:399\u2013403. doi: 10.1002\/ijc.11531","journal-title":"Int J Cancer"},{"key":"9206_CR24","first-page":"2838","volume":"61","author":"SC Wang","year":"2001","unstructured":"Wang SC, Makino K, Su LK, Pao AY, Kim JS, Hung MC (2001) Ultraviolet irradiation induces BRCA2 protein depletion through a p53-independent and protein synthesis-dependent pathway. Cancer Res 61:2838\u20132842","journal-title":"Cancer Res"},{"key":"9206_CR25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0360-3016(01)02661-X","volume":"52","author":"S Galper","year":"2002","unstructured":"Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS et al (2002) Second non-breast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 52:406\u2013414. doi: 10.1016\/S0360-3016(01)02661-X","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-008-9206-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-008-9206-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-008-9206-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:45:58Z","timestamp":1559252758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-008-9206-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9206"],"URL":"https:\/\/doi.org\/10.1007\/s10689-008-9206-8","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,5]]}}}